Realization of the Recommendation for Influenza Vaccination in Pregnant Women

NCT03007797 | Completed

• 1 other identifier: homwo 01
• Study Type: observational
• Target: 236
• Locations: 0 countries
• Sites: N/A

Brief Summary

Introduction: In 2010, the vaccination recommendations for pregnant women against seasonal influenza were published by the German Standing Committee on Vaccination (STIKO). This work deals with the immunization coverage and the influencing factors. Method: A cross-sectional study was realized at two Level 1 perinatal centers in two German federal states during the influenza saisons 2012/2013 and 2013/2014. Pregnant women were interviewed by using a standardized and pre-tested questionnaire covering their knowledge about the influenza vaccination and other factors influencing the vaccination decision. Furthermore, data from the vaccination card and the pregnancy record booklet have been evaluated.

Conditions

Coverage Rate of Vaccination for Influenza

Outcome Measures

Primary Outcomes (1)

• Influenza Vaccination rate in Pregnant Women

  The first aim of the study is check how many pregnant women are following the new german recommendation of influenza vaccination in pregnancy.

  02/12- 02/14

Secondary Outcomes (1)

• influencing factors on the Influenza vaccination rate

  02/12- 02/14

Study Arms (1)

vaccination rate- pregnant- influenca

Behavioral: vaccination rate for influenza

Interventions

vaccination rate for influenza BEHAVIORAL

vaccination rate- pregnant- influenca

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

236 pregnant women in 2 centers

You may qualify if:

• pregnant women older than 18
• vaccination records
• signatetd letter of agreement

You may not qualify if:

• younger than 18

Sponsors & Collaborators

• University Hospital, Saarland: lead
• Klinikum Worms: collaborator

MeSH Terms

Interventions

Influenza Vaccines

Intervention Hierarchy (Ancestors)

Viral Vaccines; Vaccines; Biological Products; Complex Mixtures

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 7, 2016
• First Posted: January 2, 2017
• Study Start: December 1, 2012
• Primary Completion: February 1, 2014
• Study Completion: February 1, 2014
• Last Updated: January 2, 2017

Record last verified: 2016-12